GeoVax Begins AIDS Vaccine Human Trials

August 21, 2007
BioPharm International Editors

GeoVax Labs, Inc. (Atlanta, GA, www.geovax.com), has announced an early start of two new acquired immunodeficiency syndrome (AIDS) vaccine clinical (human) trials.

GeoVax Labs, Inc. (Atlanta, GA, www.geovax.com), has announced an early start of two new acquired immunodeficiency syndrome (AIDS) vaccine clinical (human) trials. These FDA-compliant trials were earlier scheduled to start later in 2007 and are the third and fourth in a series of four clinical trials intended to evaluate both human safety and immune responses to GeoVax’s HIV/AIDS vaccines.

Related Content:

News